TIG
Desconocido
SEPCELL: Title of Proposal Restoring the immune system homeostasis and organ function in severe community ac...
TIGENIX NV
participó en un
H2020:
H2020-PHC-2014-2015
Sepsis is defined as a systemic inflammatory response to infection, while severe sepsis (SS) is a sepsis complicated by acute organ dysfunct...
2015-10-01 - 2022-04-30 | Financiado
2015-10-01 - 2022-04-30 | Financiado
REGENER-AR: Bringing Regenerative Medicine into the market Allogeneic eASCs Phase IB IIA clinical trial for tre...
TIGENIX NV
tramitó un
FP7:
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0....
Financiado
Financiado
TREAT OA: Translational Research in Europe Applied Technologies for Osteoarthritis
TIGENIX NV
participó en un
FP7:
TREAT-OA will address the need for better treatment and diagnostics for osteoarthritis (OA) - the most common cause of disability in Europe....
Financiado
Financiado
* No se disponen de datos de la empresa actual.